Andrea D. Coviello, MD, is a reproductive endocrinologist and practicing clinician and researcher at Boston University School of Medicine (Boston, MA) where she holds appointments in the Section of Preventive Medicine and Epidemiology and the Section of Endocrinology, Diabetes and Nutrition. Her research focuses on the neuroendocrine control of reproduction and metabolism and the influence of reproductive hormones on metabolism and cardiovascular disease, with particular emphasis on gender differences in the relationships between hormones and chronic disease.
Dr. Coviello's research program encompasses clinical and genetic epidemiology studies in population-based cohorts such as the Framingham Heart Study (FHS) and the National Health and Nutrition Examination Study (NHANES). She works with the global Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium as a FHS investigator on the genetic influences of reproductive traits such as menopause and gonadal and adrenal sex hormones and their relationships to health and chronic disease. Her clinical research has included clinical trials of testosterone therapy in men as well as physiologic trials of the neuroendocrine axis and intratesticular hormonal environment that control spermatogenesis. More recently, her research has focused on the metabolic disorders associated with disorders of androgen excess in women affected by polycystic ovary syndrome (PCOS). Her group is currently targeting lifestyle interventions (diet and exercise) in women with PCOS, the most common endocrinopathy in women to improve obesity and insulin resistance and prevent diabetes and cardiovascular disease.
Dr. Coviello is board certified in endocrinology as well as obesity medicine and treats both men and women with reproductive endocrine disorders at Boston University Medical Center. She has recently started a weight management clinic within the Boston University Nutrition and Weight Management Center specifically for women with PCOS, a disorder characterized by high levels of androgens associated with disproportionately high rates of obesity (50-80%).